Lidocaine Infusion in Hystroscopy

Phase 2

Completed

• Conditions: Pain
• Interventions: Drug: Diclofenac Sodium; Drug: Lidocaine Hydrochloride

• Registration Number: NCT03825016
• Lead Sponsor: Ain Shams University

Brief Summary

Lidocaine infusion in hystroscopic media versus oral diclofenac

Detailed Description

Not available

Study Timeline

• Study Start: 2017-08-01
• Study First Submitted: 2019-01-30
• Study First Submitted QC: 2019-01-30
• Study First Posted: 2019-01-31
• Status Verified: 2020-01
• Primary Completion: 2020-01-10
• Study Completion: 2020-01-10
• Last Update Submitted: 2020-01-26
• Last Update Posted: 2020-01-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 44

Inclusion Criteria

• Age 18-35 years
• BMI 18.5-30 kg/m2
• Diagnostic hystroscope

Exclusion Criteria

• Previous cervical surgery
• Cervical stenosis
• PID
• allergy to NSAID
• Gastritis or peptic ulcer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Diclofenac	Diclofenac Sodium	Oral Diclofenac
Lidocaine	Lidocaine Hydrochloride	Lidocaine Hydrochloride

Primary Outcome Measures

Name	Time	Method
Degree of pain "measured by visual analogue scale"	1 hour	measured by visual analogue scale

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital; 🇪🇬 Cairo, Egypt